Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05120999 · ClinicalTrials.gov registry record
Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
A clinical trial of Neuromuscular Blockade, sponsored by Mayo Clinic.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05120999: Completed study of Neuromuscular Blockade, sponsored by Mayo Clinic.
NCT05120999 is a study of Neuromuscular Blockade that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 11,824-participant average among 6 other Neuromuscular Blockade trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05120999, a study of Neuromuscular Blockade, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to use 2 devices to compare the difference in the amount of time it takes for each device to register complete muscle relaxation after the muscle relaxing medication is given. The comparison will be made by using electromyographic (EMG), such as TetraGraph, and acceloromyographic (AMG), such as TOFScan, monitors at the time of insertion of breathing tube.
Primary Outcome
Compare time difference from neuromuscular blockade agent administration to neuromuscular blockade onset
Conditions Studied
Interventions
- DEVICE Train of four measurement
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2022-01-14 |
What the finished NCT05120999 record still lists
NCT05120999 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 11,824-participant average among 6 other Neuromuscular Blockade trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Neuromuscular Blockade appearing as the primary indexed condition, and to 1 intervention - of which Train of four measurement is the first listed.
NCT05120999 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05120999 about?
NCT05120999 is a clinical study titled "Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring". The purpose of this research is to use 2 devices to compare the difference in the amount of time it takes for each device to register complete muscle relaxation after the muscle relaxing medication is given. The comparison will be made by using electromyographic (EMG), such as TetraGraph, and accelo...
What is the current status of trial NCT05120999?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2021-10-25. Estimated completion is 2022-01-14.
What conditions does trial NCT05120999 study?
This clinical trial studies the following conditions: Neuromuscular Blockade.
What interventions are being tested in trial NCT05120999?
The interventions under investigation include: Train of four measurement (DEVICE).
Who is sponsoring clinical trial NCT05120999?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05120999 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuromuscular Blockade
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
RECRUITING · Phase 4
-
Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison
RECRUITING
-
NMBA Reversal and Postoperative Urinary Retention
ACTIVE NOT RECRUITING
-
Understanding the Cognition and Decision Making of Community Anesthesiologists
COMPLETED
-
Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular
COMPLETED · Phase 4
-
The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI